An investigation for investors in NYSE:GMED shares concerning potential breaches of fiduciary duties by certain Globus Medical directors was announced.
Investors who are current long term investors in Globus Medical Inc (NYSE:GMED) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm for current long term investors in NYSE:GMED stocks follows a lawsuit filed recently against Globus Medical Inc over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE:GMED stocks, concerns whether certain Globus Medical officers and directors are liable in connection with the allegations made in that lawsuit. The plaintiff alleges that the defendants issued materially false and misleading statements to investors and/or failed to disclose that Globus Medical’s relationship with a significant distributor was deteriorating, that such deterioration was negatively impacting Globus Medical’s financial performance, and that as a result of the foregoing, defendants’ statements about Globus Medical’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
Those who purchased NYSE:GMED shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com